Login / Signup

Osteoblasts remotely supply lung tumors with cancer-promoting SiglecFhigh neutrophils.

Camilla EngblomChristina PfirschkeRapolas ZilionisJanaina Da Silva MartinsStijn A BosGabriel CourtiesSteffen RickeltNicolas SevereNinib BaryawnoJulien FagetVirginia SavovaDavid ZemmourJaclyn KlineMarie SiwickiChristopher S GarrisFerdinando PucciHsin-Wei LiaoYi-Jang LinAndita NewtonOmar K YaghiYoshiko IwamotoBenoit TricotGregory R WojtkiewiczMatthias NahrendorfVirna Cortez-RetamozoEtienne MeylanRichard O HynesMarie B DemayAllon M KleinMiriam A BredellaDavid T ScaddenRalph WeisslederMikaël J Pittet
Published in: Science (New York, N.Y.) (2018)
Bone marrow-derived myeloid cells can accumulate within tumors and foster cancer outgrowth. Local immune-neoplastic interactions have been intensively investigated, but the contribution of the systemic host environment to tumor growth remains poorly understood. Here, we show in mice and cancer patients (n = 70) that lung adenocarcinomas increase bone stromal activity in the absence of bone metastasis. Animal studies reveal that the cancer-induced bone phenotype involves bone-resident osteocalcin-expressing (Ocn+) osteoblastic cells. These cells promote cancer by remotely supplying a distinct subset of tumor-infiltrating SiglecFhigh neutrophils, which exhibit cancer-promoting properties. Experimentally reducing Ocn+ cell numbers suppresses the neutrophil response and lung tumor outgrowth. These observations posit osteoblasts as remote regulators of lung cancer and identify SiglecFhigh neutrophils as myeloid cell effectors of the osteoblast-driven protumoral response.
Keyphrases